EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epigenetic Regulation of Cell Cycle Control in Colorectal Cancer: Molecular Mechanisms and Therapeutic Perspectives

Srinivasa B iD, Devika P Jeeragyal iD, Kiran Velukuri iD, Amarnath Reganti iD, Vaheedha S iD, Vinodhkumar Ramalingam iD, Rajasekar Sreerama iD, Neelima Grandhe iD, Praveen Hoogar iD

Advanced Pharmaceutical Bulletin · 23.05.2026

DOI: 10.34172/apb.47190 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 23.05.2026. Verfasst von Srinivasa B und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, …. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Epigenetic dysregulation is increasingly recognized as a fundamental driver of cell cycle checkpoint failure in colorectal cancer. Beyond genetic mutations, epigenetic mechanisms provide a dynamic and potentially reversible layer of control over cyclin-dependent kinase activity and tumor progression. This mechanistic critical review examines how epigenetic alterations reshape cell cycle regulation in colorectal cancer and evaluates their translational relevance.

Methods

This review adopts a critical mechanistic approach, integrating and interpreting evidence from experimental, translational and clinical studies addressing epigenetic regulation of cell cycle control in colorectal cancer. Rather than following a systematic review framework, the literature was evaluated conceptually to identify dominant mechanisms, areas of convergence and unresolved controversies.

Results

Evidence indicates that aberrant DNA methylation, histone modifications and chromatin remodeling converge to repress key cyclin-dependent kinase inhibitors including p16INK4a, p21Cip1 and p27Kip1. These epigenetic alterations sustain cyclin–CDK activity thereby promote bypass of G1/S checkpoint control and facilitate uncontrolled proliferation. Importantly, epigenetic heterogeneity across colorectal tumors contributes to variable therapeutic responses and resistance to both conventional and epigenetic-targeted therapies.

Conclusion

Epigenetic control of cell cycle checkpoints represents a central and therapeutically exploitable mechanism in colorectal cancer. A mechanistic understanding of these regulatory networks highlights opportunities for rational combination strategies and precision-based interventions while underscoring current knowledge gaps that warrant further investigation.

Schlagwörter

Stichwörter der Autor:innen

Cell cycleColorectal neoplasmsCyclin-dependent kinasesDNA methylationEpigenesisHistone modification

Autor:innen und Institutionen

  • Department of Pharmacology, Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai Tamil Nadu, India.
  • Department of Community Medicine, Apollo Institute of Medical Sciences And Research Chittoor, India.
  • Department of Physiotherapy, Apollo College of Physiotherapy, the Apollo Knowledge Centre, Murukambattu, Chittoor 517127, India.
  • Division of Allied Health Sciences, School of Health Sciences, the Apollo University, Murukambattu, Chittoor, India.
  • Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
  • Department of Pharmaceutical Chemistry, Apollo Institute of Pharmaceutical Sciences, The Apollo University, The Apollo Knowledge City Saketa, Chittoor, India.

ORCID-Profile: Srinivasa B, Devika P Jeeragyal, Kiran Velukuri, Amarnath Reganti, Vaheedha S, Vinodhkumar Ramalingam, Rajasekar Sreerama, Neelima Grandhe, Praveen Hoogar

Zitieren

APA

B, S., Jeeragyal, D. P., Velukuri, K., Reganti, A., S, V., Ramalingam, V., Sreerama, R., Grandhe, N., & Hoogar, P. (2026). Epigenetic Regulation of Cell Cycle Control in Colorectal Cancer: Molecular Mechanisms and Therapeutic Perspectives. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.47190

Vancouver

B S, Jeeragyal DP, Velukuri K, Reganti A, S V, Ramalingam V, et al. Epigenetic Regulation of Cell Cycle Control in Colorectal Cancer: Molecular Mechanisms and Therapeutic Perspectives. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.47190

BibTeX
@article{B2026,
  author = {B, Srinivasa and Jeeragyal, Devika P and Velukuri, Kiran and Reganti, Amarnath and S, Vaheedha and Ramalingam, Vinodhkumar and Sreerama, Rajasekar and Grandhe, Neelima and Hoogar, Praveen},
  title = {Epigenetic Regulation of Cell Cycle Control in Colorectal Cancer: Molecular Mechanisms and Therapeutic Perspectives},
  journal = {Advanced Pharmaceutical Bulletin},
  year = {2026},
  doi = {10.34172/apb.47190}
}
Kostenlos starten →